Novel angular furo and thieno-quinolinones: synthesis and preliminary photobiological studies
摘要:
A number of new furo and thienoquinolinones carrying an electron-withdrawing function or unsubstituted at the position 3 were synthesized in order to obtain new potential photochemotherapeutic agents with increased anti proliferative activity and decreased toxic side effects. Our interest in studying the SAR of these derivatives also prompted us to investigate the influence of N-methylation on biological activity, by preparing N-methyl derivatives. The antiproliferative activity of all the newly synthesized compounds was evaluated and compared to 8-methoxypsoralen (8-MOP), the drug widely used in PUVA-therapy. The 3-unsubstituted thienoquinolinones were generally the most potent derivatives, followed by the furo-analogues. In particular. the unsubstituted thieno[2.3-h]quinoline-2(1H)one showed the highest activity in T2 bacteriophage, HeLa cells and Ehrlich cells tests. All the compounds, assayed on Escherichia coli WP2 TM9, showed a similar mutagenic activity, very close to that of 8-MOP. Except for 2-oxo-1,2-dihydrothieno[2.3-h]quinoline-3-carboxylic acid, which appeared to be very effective, all compounds generated singlet oxygen to slightly larger amounts when compared to 8-MOP. The N-methyl analogues only induced moderate skin erythemas on albino guinea pigs, while all other derivatives appeared to be entirely inactive. On the basis of these results, the unsubstituted thieno[2,3h]quinoline 2(1H)one seems to be the most interesting potential drug for PUVA photochemotherapy and photopheresis. (C) 2002 Elsevier Science Ltd. All rights reserved.
Reaction of ketenes with<i>N,N</i>-disubstituted α-aminomethyleneketones.<b>XIX</b>. Synthesis of<i>N,N</i>-disubstituted 4-amino-3-phenyl-2<i>H</i>-furo[2,3-<i>h]</i>-1-benzopyran-2-ones (4-amino-3-phenylangelicins). Crystal and molecular structure of 3-Phenylangelicin
phenylchloroketene to N,N-disubstituted 5-aminomethylene-6,7-dihydrobenzo[b]- furan-4(5H)-ones gave the corresponding adducts, namely N,N-disubstituted 4-amino-3-chloro-3,4,5,6-tetra- hydro-3-phenyl-2H-furo[2,3-h]-l-benzopyran-2-ones II, which were dehydrochlorinated with DBN to N,N-disubstituted 4-amino-5,6-dihydro-3-phenyl-2H-furo[2,3-h]-1-benzopyran-2-ones III. Compounds III afforded the title compounds
苯氯乙烯酮的1,4-环加成至N,N-二取代的5-氨基亚甲基-6,7-二氢苯并[ b ]-呋喃-4(5 H)-ones得到相应的加合物,即N,N-二取代的4-氨基- 3-氯-3,4,5,6-四氢-3-苯基-2 H-呋喃并[2,3 - h ] -1-苯并吡喃-2-酮s II,用DBN脱氯化氢成N,N -二取代的4-氨基-5,6-二氢-3-苯基-2 H-呋喃并[2,3 - h ] -1-苯并吡喃-2-酮III。化合物III通过用DDQ脱氢得到标题化合物IV。在环加成步骤中,3-苯基AngelicinV几乎总是形成的,其结构由1 H-nmr迁移试剂数据和X射线晶体结构确定,可能是从II开始,通过二取代氨基的脱氯化氢,脱氢和氢解作用而形成的。在环加成步骤中,或者在大多数情况下,在脱氯化氢步骤中,通过氧化铝色谱法实现V的分离。
The present invention relates to substituted imidazolyl-5,6-dihydrobenzo[n]isoquinoline compounds and methods of synthesizing these compounds. The present invention also relates to pharmaceutical compositions containing substituted imidazolyl-5,6-dihydrobenzo[n]isoquinoline compounds and methods of treating cell proliferative disorders, such as cancer, by administering these compounds and pharmaceutical compositions to subjects in need thereof.